CRDL logo

Cardiol Therapeutics (CRDL)

Profile

Full Name

Cardiol Therapeutics Inc.

Ticker Symbol

CRDL

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

Canada

IPO

January 15, 2019

Indexes

Not included

Website

http://www.cardiolrx.com

Employees

18

Key Details

Price

$1.01(-4.72%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.37(-14.15% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.01
CRDL price is $1.01

30-Day Relative Volume

0.86
CRDL 30-day relative volume is 0.86

Price Performance

Price Most recent change

-4.72%
CRDL price was down -4.72% on Apr 16, 2025

Price YTD change

-21.09%
CRDL price is down -21.09% since January 1st

Price 1-year change

-42.29%
CRDL price is down -42.29% year-on-year

Price 3-year change

-50.73%
CRDL price is down -50.73% over the past 3 years

Price Range

Price All-time high

$10.00
CRDL price is currently -89.90% below its historical high of $10.00

Price 3-year low

$0.45
CRDL price is currently +124.44% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$83.44M
CRDL market capitalization is $83.44 million

Market cap 3-year change

-34.28%
CRDL market capitalization is down -34.28% over the past 3 years

Market cap All-time high

$213.88M
CRDL market capitalization is currently -60.99% below its historical high of $213.88 million

Market cap sector rank

46.63%
CRDL market capitalization is higher than 46.63% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+21.01%
CRDL shares outstanding is up +21.01% year-on-year

Shares Outstanding 3-Year Change

+33.4%
CRDL shares outstanding is up +33.4% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.22
CRDL beta is 1.22

200-day SMA

$1.63
CRDL price is currently -37.93% below its 200-day simple moving average

50-day SMA

$1.11
CRDL price is currently -9.10% below its 50-day simple moving average

RSI

49.78
CRDL 14-day relative strength index is 49.78

Volume

0.86
CRDL 30-day relative volume is 0.86

ATR

$0.10
CRDL average true range is $0.10

10-day Historical Volatility

108.53%
CRDL 10-day historical volatility is 108.53%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
CRDL annual revenue value is unknown

Revenue Analysts estimate

-
CRDL annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
CRDL annual revenue 1-year change is unknown

Revenue Sector rank

-
CRDL annual revenue is unknown

EPS

EPS

-$0.37
CRDL annual earnings per share is -$0.37

EPS Analysts estimate

-$0.38
CRDL annual earnings per share is currently -2.11% lower than the consensus analysts' forecast

EPS 1-year change

-14.15%
CRDL annual earnings per share is down -14.15% year-on-year

EPS Sector rank

71.82%
CRDL annual earnings per share is higher than 71.82% of companies in Healthcare sector

Profit

Gross profit

-
CRDL annual gross profit value is unknown

Gross margin

-
CRDL annual gross profit margin value is unknown

Operating profit

-$29.38M
CRDL annual operating income is -$29.38 million

Operating margin

-
CRDL annual operating profit margin value is unknown

Net income

-$26.76M
CRDL annual net profit is -$26.76 million

Net margin

-
CRDL annual net profit margin value is unknown

Expenses

Total expenses

$29.38M
CRDL annual total expenses is $29.38 million

Operating expenses

$29.38M
CRDL annual total operating expenses is $29.38 million

Cost of goods sold

-
CRDL annual cost of goods sold value is unknown

Selling, general & administrative expenses

$19.16M
CRDL annual SGA is $19.16 million

Depreciation and amortization

$272.20K
CRDL annual depreciation & amortization is $272.20 thousand

Interest expense

-
CRDL annual interest expense value is unknown

Income tax

-
CRDL annual income tax value is unknown

EBIT & EBITDA

EBIT

-$29.38M
CRDL annual earnings before interest & taxes is -$29.38 million

EBITDA

-$29.11M
CRDL annual EBITDA is -$29.11 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$22.20M
CRDL annual total assets is $22.20 million

Non current assets

$136.30K
CRDL annual long term assets is $136.30 thousand

Current assets

$22.07M
CRDL annual total current assets is $22.07 million

Cash and cash equivalents

$21.31M
CRDL annual cash & cash equivalents is $21.31 million

Accounts receivable

$69.90K
CRDL annual accounts receivable is $69.90 thousand

Inventory

-
CRDL annual inventory value is unknown

Liabilities

Total liabilities

$4.97M
CRDL annual total liabilities is $4.97 million

Long term liabilities

$87.50K
CRDL annual total long term liabilities is $87.50 thousand

Current liabilities

$4.88M
CRDL annual total current liabilities is $4.88 million

Accounts payable

-
CRDL annual accounts payable value is unknown

Debt

Total debt

$110.50K
CRDL annual total debt is $110.50 thousand

Total debt 1-year change

-15.91%
CRDL annual total debt is down -15.91% year-on-year

Long term debt

$87.50K
CRDL annual long term debt is $87.50 thousand

Short term debt

$23.00K
CRDL annual short term debt is $23.00 thousand

Equity & Capital

Shareholders equity

$17.23M
CRDL annual stockholders equity is $17.23 million

Book value

$17.23M
CRDL annual book value is $17.23 million

Retained earnings

-$124.90M
CRDL annual retained earnings is -$124.90 million

Working capital

$17.18M
CRDL annual working capital is $17.18 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$18.28M
CRDL annual cash flow from operations is -$18.28 million

Cash from operations 1-year change

+1.97%
CRDL annual cash flow from operations is up +1.97% year-on-year

Cash from investing

-$15.50K
CRDL annual cash flow from investing activities is -$15.50 thousand

Cash from investing 1-year change

+67.44%
CRDL annual cash flow from investing activities is up +67.44% year-on-year

Cash from financing

$13.74M
CRDL annual cash flow from financing activities is $13.74 million

Cash from financing 1-year change

+33621.95%
CRDL annual cash flow from financing activities is up +33621.95% year-on-year

CAPEX

CAPEX

-
CRDL annual capital expenditures value is unknown

CAPEX 1-year change

-
CRDL annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$18.30M
CRDL annual free cash flow is -$18.30 million

Free cash flow 1-year change

+2.13%
CRDL annual free cash flow is up +2.13% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CRDL annual gross profit margin value is unknown

Operating margin

-
CRDL annual operating profit margin value is unknown

Net margin

-
CRDL annual net profit margin value is unknown

ROA & ROE

ROA

-120.51%
CRDL annual return on assets is -120.51%

ROE

-155.29%
CRDL annual return on equity is -155.29%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CRDL price to earnings ratio value is unknown

PE ratio Sector rank

-
CRDL price to earnings ratio is unknown

PB Ratio

PB ratio

4.84
CRDL price to book ratio is 4.84

PB ratio Sector rank

82.54%
CRDL price to book ratio is higher than 82.54% of companies in Healthcare sector

PS Ratio

PS ratio

-
CRDL price to sales ratio value is unknown

PS ratio Sector rank

-
CRDL price to sales ratio is unknown

Enterprise value

Enterprise value

$62.24M
CRDL enterprise value is $62.24 million

Enterprise value Sector rank

44.26%
CRDL enterprise value is higher than 44.26% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-2.14
CRDL EV/EBITDA is -2.14

EV/EBITDA Sector rank

30.43%
CRDL EV/EBITDA is higher than 30.43% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.52
CRDL annual current ratio is 4.52

Quick ratio

-
CRDL annual quick ratio value is unknown

Leverage

Debt to equity

0.01
CRDL annual debt to equity ratio is 0.01

Interest coverage ratio

-
CRDL annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CRDL piotroski f-score value is unknown

Altman Z-Score

-
CRDL altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 7, 25 HC Wainwright & Co.
Buy
Feb 24, 25 HC Wainwright & Co.
Buy
Dec 18, 24 HC Wainwright & Co.
Buy
Nov 20, 24 HC Wainwright & Co.
Buy
Oct 24, 24 HC Wainwright & Co.
Buy
Jun 26, 24 Roth MKM
Buy
Jun 14, 24 HC Wainwright & Co.
Buy
Jun 7, 24 HC Wainwright & Co.
Buy
May 23, 24 Canaccord Genuity
Buy
May 14, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

ICAD logo
iCAD (ICAD)
HLVX logo
HilleVax (HLVX)
CRVO logo
CervoMed (CRVO)
Climb Bio (CLYM)
SRZN logo
Surrozen (SRZN)
MBOT logo
Microbot Medical (MBOT)
Basel Medical Group Ltd (BMGL)
VOR logo
Vor Biopharma (VOR)
Elutia (ELUT)
  • What is the ticker symbol for Cardiol Therapeutics?
  • Does Cardiol Therapeutics pay dividends?
  • What sector is Cardiol Therapeutics in?
  • What industry is Cardiol Therapeutics in?
  • What country is Cardiol Therapeutics based in?
  • When did Cardiol Therapeutics go public?
  • Is Cardiol Therapeutics in the S&P 500?
  • Is Cardiol Therapeutics in the NASDAQ 100?
  • Is Cardiol Therapeutics in the Dow Jones?
  • When was Cardiol Therapeutics's last earnings report?
  • When does Cardiol Therapeutics report earnings?

What is the ticker symbol for Cardiol Therapeutics?

The ticker symbol for Cardiol Therapeutics is NASDAQ:CRDL

Does Cardiol Therapeutics pay dividends?

No, Cardiol Therapeutics does not pay dividends

What sector is Cardiol Therapeutics in?

Cardiol Therapeutics is in the Healthcare sector

What industry is Cardiol Therapeutics in?

Cardiol Therapeutics is in the Drug Manufacturers - Specialty & Generic industry

What country is Cardiol Therapeutics based in?

Cardiol Therapeutics is headquartered in Canada

When did Cardiol Therapeutics go public?

Cardiol Therapeutics's initial public offering (IPO) was on January 15, 2019

Is Cardiol Therapeutics in the S&P 500?

No, Cardiol Therapeutics is not included in the S&P 500 index

Is Cardiol Therapeutics in the NASDAQ 100?

No, Cardiol Therapeutics is not included in the NASDAQ 100 index

Is Cardiol Therapeutics in the Dow Jones?

No, Cardiol Therapeutics is not included in the Dow Jones index

When was Cardiol Therapeutics's last earnings report?

Cardiol Therapeutics's most recent earnings report was on Nov 14, 2024

When does Cardiol Therapeutics report earnings?

The next expected earnings date for Cardiol Therapeutics is May 14, 2025
On this page